Long-term follow-up of atrial fibrillation patients in the NASPEAF study. Prospective evaluation of different antiplatelet treatments;Seguimiento a largo plazo de enfermos con fibrilación auricular del estudio NASPEAF. Control prospectivo de otros tratamientos antiplaquetarios

Revista Espanola de Cardiologia

Volumn 62, Issue 9, 2009, Pages 992-1000

  Bover, Ramón ^a   Pérez Gómez, Francisco ^a   Maluenda, María P ^a   Asenjo, Susana ^a   Pérez Saldaña, Rosario ^b   Igea, Ángel ^b   Suárez, Marta ^a   Coleto, Dulcenombre ^a   Fernández, Cristina ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b Anticoagulation Unit   (Spain)

Author keywords

Anticoagulation; Aspirin; Atrial fibrillation; Stroke; Triflusal

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; TRIFLUSAL;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; STROKE;

AGED; ASPIRIN; ATRIAL FIBRILLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; SALICYLATES; TIME FACTORS;

EID: 70349255614     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)72097-4     Document Type: Article

References (25)

1. C. Van Walraven, R.G. Hart, D.E. Singer, A. Laupacis, S. Connolly, and P. Petersen Oral anticoagulants versus aspirin in nonvalvular atrial fibrillation. An individual patient meta-analysis JAMA 288 2002 2441 2448 (Pubitemid 35340540)
2. J.L. Halperin Ximegalatran compared with warfarin for prevention of thromboembolism in patients with nonrheumatic atrial fibrillation: rationale, objectives and design of a pair of clinical studies and baseline patients characteristics (Sportif III and V) Am Heart J 146 2003 431 438
3. F. Pérez-Gómez, E. Alegría, J. Berjón, J.A. Iriarte, J. Zumalde, A. Salvador NASPEAF Investigators Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation. A randomized multicenter study J Am Coll Cardiol 44 2004 1557 1566 (Pubitemid 39377708)
4. F. Pérez-Gómez, A. Salvador, J. Zumalde, J.A. Iriarte, J. Berjón, and E. Alegría, et al. Effects of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial Eur Heart J 27 2006 960 967
5. F. Pérez-Gómez, J.A. Iriarte, J. Zumalde, J. Berjón, A. Salvador, and E. Alegría Antithrombotic therapy in elderly patients with atrial fibrillation: effects and bleeding complications: a stratified analysis of the NASPEAF randomized trial Eur Heart J 28 2007 996 1003 (Pubitemid 47343894)
6. The Stroke Prevention in Atrial Fibrillation Investigators Stroke Prevention in Atrial Fibrillation Study. Final results Circulation 84 1991 527 539
7. The Stroke Prevention in Atrial Fibrillation Investigators Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study Lancet 343 1994 687 691 (Pubitemid 24087846)
8. P. Petersen, G. Boysen, J. Godtfredsen, E.D. Andersen, and H. Andersen Placebo controlled, randomized trial on warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study Lancet 1 1989 175 179 (Pubitemid 19038801)
9. S.J. Connolly, A. Laupacis, M. Gent, R.S. Roberts, J.A. Cairns, C. Joiner For the CAFA Study Coinvestigators Canadian Atrial Fibrillation Anticoagulation (CAFA) Study J Am Coll Cardiol 18 1991 349 355
10. J.P. Ioannidis, S.J. Evans, P.C. Gøtzsche, R.T. O'Neill, D.G. Altman, K. Schulz CONSORT Group Better reporting of harms in randomized trials: An extension of the CONSORT Statement Arch Intern Med 141 2004 781 788 (Pubitemid 39524916)
11. A. Oden, M. Fahlén, and R.G. Hart Optimal INR for prevention of stroke and death in atrial fibrillation. A critical appraisal Thom Res 117 2006 493 499 (Pubitemid 43326133)
12. EAFT (European Atrial Fibrillation Trial Study Group) Secondary prevention in non rheumatic atrial fibrillation after transient ischemic attack or minor stroke Lancet 342 1993 1255 1262 (Pubitemid 23338782)
13. E.M. Hylek, S.J. Skates, M.A. Sheehan, and D.E. Singer An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation N Engl J Med 335 1996 540 546
14. R.H. Falk Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation J Am Coll Cardiol 44 2004 1567 1569 (Pubitemid 39369786)
15. Stroke Prevention in Atrial Fibrillation Investigators Adjusteddose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial Lancet 348 1996 633 638
16. A.L. Gullov, B.G. Koefoed, and P. Petersen Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation Arch Intern Med 159 1999 1322 1326 (Pubitemid 29293594)
17. D.M. Monroe, M. Hoffman, and H.R. Roberts Platelets and thrombin generation Arterioscler Thromb Vasc Biol 22 2002 1381 1389 (Pubitemid 35050717)
18. A.I. Schafer Coagulation cascade: an overview J. Loscalzo A.I. Schafer Thrombosis and haemorrhage 1994 Blackwell Scientific Boston
19. R.G. MacFarlane An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier Nature 202 1994 98 99
20. R. De Caterina, S. Husted, L. Wallentin, G. Agnelli, F. Bachmann, and C. Baigent Anticoagulants in heart disease: current status and perspectives Eur Heart J 28 2007 880 913 (Pubitemid 47343588)
21. D. Massel, and S.H. Kittle Risk and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves. A meta-analysis J Am Coll Cardiol 37 2001 569 578 (Pubitemid 32147272)
22. M. Harlen, M. Abdelugor, P. Smith, J. Erikssen, and H. Arnesen Warfarin, aspirin or both after myocardial infarction N Engl J Med 347 2003 969 974
23. A.B. Hawthorne, Y.R. Mahida, A.T. Coke, and C.J. Hawkey Aspirin induced gastric mucosal damage: prevention by enteric coating and relation to prostaglanding synthesis Br J Clin Pharmacol 32 1991 77 83
24. P.J. Prichard, G.K. Kitchingman, R.P. Walt, T.K. Daneshmend, and C.J. Hawkey Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin BMJ 298 1989 493 496
25. F.K. Chan, J.Y. Ching, L.C. Hung, V.W. Wong, V.K. Leung, and N.N. Kung Clopidogrel versus aspirin and esomeprazol to prevent gastric ulcer bleeding N Engl J Med 352 2005 238 244 (Pubitemid 40110812)